PDS Biotechnology grants director 22,700 stock options

The options vest over three annual installments and remain subject to continued director service through each vesting date.

Rhea-AI Filing Summary

PDS Biotechnology Corp director Bruce Wendel received a grant of stock options to buy 22,700 shares of common stock at an exercise price of $1.13 per share. The options vest in three equal annual installments beginning on the first anniversary of the October 18, 2026 grant date, subject to his continued service as a director through each vesting date, and expire October 18, 2036.

Insider Trade Summary

Grant/Award: 22,700 shares

Grant/Award 1 txn

Insider Wendel Bruce

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	22,700	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 22,700 contracts (Direct)

Footnotes (1)

1. F1. The Stock Option shall vest in three (3) equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such dates.

Key Figures

Stock options granted: 22,700 options Underlying common shares: 22,700 shares Exercise price: $1.13 per share +2 more

5 metrics

Stock options granted 22,700 options Granted October 18, 2026

Underlying common shares 22,700 shares Shares the options may be used to buy

Exercise price $1.13 per share Stock option exercise price

Vesting schedule 3 equal annual installments Beginning on the first anniversary of the grant date, subject to continued director service through each vesting date

Expiration date October 18, 2036 Stock options

Key Terms

Stock Option, vest, exercise price

3 terms

Stock Option financial

"The Stock Option shall vest in three (3) equal annual installments"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

vest financial

"shall vest in three (3) equal annual installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercise price financial

"conversion_or_exercise_price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did Bruce Wendel receive from PDSB?

Bruce Wendel received options to buy 22,700 shares of PDS Biotechnology Corp common stock. The options have an exercise price of $1.13 per share.

When do Bruce Wendel’s PDSB stock options vest and expire?

The options vest in three equal annual installments, beginning on the first anniversary of the October 18, 2026 grant date, subject to his continued service as a director through each vesting date. They expire on October 18, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/20/2026 - 08:20 PM EDT Accepted by SEC EDGAR 10/20/2026 - 08:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wendel Bruce

(Last) (First) (Middle)

C/O PDS BIOTECHNOLOGY CORP

303A COLLEGE ROAD EAST

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PDS Biotechnology Corp [ PDSB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.13	10/18/2026		A		22,700		(1)	10/18/2036	Common Stock	22,700	$0.00	22,700	D

Explanation of Responses:

1. The Stock Option shall vest in three (3) equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such dates.

	/s/ Bruce Wendel	10/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)